11q deletions in hematological malignancies

Leukemia and Lymphoma

Volumn 40, Issue 3-4, 2001, Pages 259-266

  Monni, O ^a   Knuutila, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

11q deletions; Hematological malignancies

Indexed keywords

ATM PROTEIN;

AGE; B CELL LEUKEMIA; CANCER DIAGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENE TARGETING; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; REVIEW; STRUCTURAL CHROMOSOME ABERRATION; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 0035035480     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057924     Document Type: Review

References (61)

1. Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization
2. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders
3. Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma
4. The RCK gene is associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations
5. Fusion between a novel Kruppel like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia
6. Rearrangements involving chromosome band 11q23 in acute leukemia
7. A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas
8. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia
9. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10
10. DNA copy number losses in human neoplasms
11. A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3
12. Assignment of human inhibitor of apoptosis protein (IAP) genes XIAP, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization
13. The ATM gene and protein: Possible role in genome surveillance, checkpoint controls and cellular defence against oxidative stress
14. Leukemia and lymphoma in ataxia telangiectasia
15. Alterations of the PPP2R1B gene in human lung and colon cancer
16. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities
17. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: Significance for cytogenetic analysis
18. Trisomy 12 in chronic lymphocytic leukemia: An interphase cytogenetic study
19. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL-1 translocation
20. Prognostic significance of chromosome abnormalities in chronic lymphocytic leukemia
21. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients
22. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 diagnosed patients
23. Chromosome abnormalities in chronic lymphocytic leukemia revealed by TPA as a mitogen
24. Clonal chromosome abnormalities in chronic lymphocytic leukemia patients revealed by TPA stimulation of whole blood cultures
25. Cytogenetic analysis of B-cell chronic leukemias classified according to morphological and immunophenotypic (FAB) criteria
26. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: Specific chromosome aberrations identify prognostic subgroups of patients and point loci of candidate genes
27. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival
28. Chromosome aberrations in atypical chronic lymphocytic leukemia: A cytogenetic and interphase cytogenetic study
29. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
30. Cytogenetics in CLL and related disorders
31. Karyotypic evolution in CLL: Identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease
32. Comparative genomic hybridization for the molecular cytogenetic analysis of solid tumors
33. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses
34. Frequent loss of the 11q14-q24 region in chronic lymphocytic leukemia: A study by comparative genomic hybridization
35. Discontinuous deletion at 11q23 in B cell chronic lymphocytic leukemia
36. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
37. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
38. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species
39. The ataxia telangiectasia gene product, a constitutively expressed nuclear protein that is not upregulated following genome damage
40. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion
41. Rearrangement and overexpression of the BCL1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias
42. Mantle cell lymphoma - An entity comes of age
43. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
44. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
45. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma
46. Minimal sizes of deletions detected by comparative genomic hybridization
47. Heritable fragile sites on human chromosomes. X. New folate-sensitive fragile sites: 6p23, 9p21, 9p32, and 11q23
48. Constitutive fragile sites and cancer
49. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia
50. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes
51. Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes
52. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
53. Deletions at 11q23 in different lymphoma subtypes
54. Tissue microarrays for high-throughput molecular profiling of tumor specimens
55. Use of cDNA microarray to analyse gene expression patterns in human cancer
56. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
57. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
58. Genome-wide analysis of DNA copy-number changes using cDNA microarrays